0 Σχόλια
0 Μοιράστηκε
2χλμ. Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Σχόλια 0 Μοιράστηκε 653 Views 0 Προεπισκόπηση
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Σχόλια 0 Μοιράστηκε 636 Views 0 Προεπισκόπηση
-
What Is the Market Outlook for Biosimilars in the Anticancer Drug Segment?Anticancer Drugs Market Poised for Robust Growth Through 2030 The global anticancer drugs market is experiencing significant expansion, with projections estimating an increase from USD 222.57 billion in 2023 to USD 495.07 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 12.1% during the forecast period. Curious to peek inside? Grab your sample copy of...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση